>

Ofer Gonen - CLAL BIOTECHNOLOGY Vice President

<div class='circular--portrait' style='background:#FF9E01;color: white;font-size:3em;padding-top: 40px;;'>CLA</div>
  President
Mr. Ofer Gonen was appointed Chief Executive Officer at Clal Biotechnology Industries Ltd effective March 5, 2017. His work experience includes the following roles Deputy Chief Executive Officer and Executive Vice President at the Company, Vice President at the Company and Director at a variety of companies. He holds a BS degree in Physics and Math from The Hebrew University of Jerusalem and a Masters degree in Finance and Economics from Tel Aviv University.
Age: 44  President Since 2017      
972 3 612 1616  http://www.cbi.co.il
Gonen has a Bachelors degree in Physics and Math from The Hebrew University of Jerusalem and a Masters degree in Finance and Economics from the TelAviv University.

Management Efficiency

The company has return on total asset (ROA) of (5.15) % which means that it has lost $5.15 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (1.79) % meaning that it generated substantial loss on money invested by shareholders.
The company has accumulated 52.28 M in total debt with debt to equity ratio (D/E) of 6.3 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. CLAL BIOTECHNOLOGY has Current Ratio of 3.6 suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due.

Similar Executives

Showing few of many executives

PRESIDENT Since

Ido LilianICL ISRAEL CHEM
2014
Osi SesslerICL ISRAEL CHEM
2008
Karl MielkeICL ISRAEL CHEM
2013
Ronnie ShushanICL ISRAEL CHEM
2014
Hezi IsraelICL ISRAEL CHEM
2012
Lizette KillianICL ISRAEL CHEM
2015
Lilach HarelICL ISRAEL CHEM
2019
Kobi AltmanICL ISRAEL CHEM
2015
Rani LoebensteinICL ISRAEL CHEM
2017
Amir BenitaICL ISRAEL CHEM
2012
Michael HazzanICL ISRAEL CHEM
2012
Eli GlazerICL ISRAEL CHEM
2018
Anat TalKtalavICL ISRAEL CHEM
2018
Yakir MenasheICL ISRAEL CHEM
2013
Herzel NivICL ISRAEL CHEM
2008
Eli AmitICL ISRAEL CHEM
2002
Ilana FahimaICL ISRAEL CHEM
2018
Ofer LifshitzICL ISRAEL CHEM
2018

Company Summary

Clal Biotechnology Industries Ltd. is a private equity and venture capital firm specializing in development stage, pre-clinical incubation, seed, start-up, early venture, emerging growth, mid venture, late venture, PIPEs, and growth capital stages of financing. It operates as a subsidiary of Clal Industries and Investments Ltd. CLAL BIOTECHNOLOGY operates under Biotechnology classification in Israel and is traded on Tel Aviv Stock Exchange.CLAL BIOTECHNOLOGY (CBI) is traded on Tel Aviv Stock Exchange in Israel and employs 14 people.

CLAL BIOTECHNOLOGY Leadership Team

Ofer Goldberg, VPView
Sigalia Heifetz, DirectorView
Shmuel Rubinstein, External DirectorView
Tomer Babai, DirectorView
Dafna Gruber, DirectorView
Aharon Schwartz, DirectorView
Gavriel Barabash, DirectorView
Isaac Kohlberg, DirectorView
Nofar Malovani, DirectorView
Assaf Segal, CFOView
Ofer Gonen, Vice PresidentView
Avraham Fischer, Chairman of the BoardView
Yuval Yanai, External DirectorView
Julian Adams, President Chief Scientific OfficerView
Orit Lidor, VP and General CounselView

Stock Performance Indicators

Did you try this?

Run Portfolio Suggestion Now

   

Portfolio Suggestion

Get suggestions outside of your existing asset allocation including your own model portfolios
All  Next Launch Module

CLAL BIOTECHNOLOGY Pair Correlation

Equities Pair Trading Analysis

Correlation analysis and pair trading evaluation for Motorola Solutions and FRANKLIN WIRELESS. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Check out Trending Equities. Please also try Pair Correlation module to compare performance and examine historical correlation between any two equity instruments.